惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

WordPress大学
WordPress大学
Engineering at Meta
Engineering at Meta
D
DataBreaches.Net
月光博客
月光博客
Recent Announcements
Recent Announcements
Google DeepMind News
Google DeepMind News
U
Unit 42
腾
腾讯CDC
爱范儿
爱范儿
J
Java Code Geeks
有赞技术团队
有赞技术团队
Blog — PlanetScale
Blog — PlanetScale
N
Netflix TechBlog - Medium
B
Blog
Stack Overflow Blog
Stack Overflow Blog
GbyAI
GbyAI
T
The Blog of Author Tim Ferriss
小众软件
小众软件
freeCodeCamp Programming Tutorials: Python, JavaScript, Git & More
Y
Y Combinator Blog
大猫的无限游戏
大猫的无限游戏
Microsoft Azure Blog
Microsoft Azure Blog
T
Tailwind CSS Blog
钛媒体：引领未来商业与生活新知
钛媒体：引领未来商业与生活新知

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4...
2026-05-26 · via All Articles on Seeking Alpha

Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2026 Earnings Call May 25, 2026 6:00 PM EDT

Company Participants

Marcus Driller - Vice President of Corporate
Lewis Gradon - MD, CEO & Executive Director
Lyndal York - Chief Financial Officer
Justin Callahan - VP of Sales & Marketing
Andy Niccol - Chief Operating Officer

Conference Call Participants

Rob Morrison - Craigs Investment Partners Limited, Research Division
Lyanne Harrison - BofA Securities, Research Division
Saul Hadassin - Barrenjoey Markets Pty Limited, Research Division
Chris Cooper - JPMorgan Chase & Co, Research Division
Sacha Krien - E&P, Research Division
Davinthra Thillainathan - Goldman Sachs Group, Inc., Research Division
Dan Hurren - MST Financial Services Pty Limited, Research Division
Adrian Allbon - Jarden Limited, Research Division
Ben Crozier - Forsyth Barr Group Ltd., Research Division
Marcus Curley - UBS Investment Bank, Research Division
Andrew Paine - CLSA Limited, Research Division
Vanessa Thomson - Jefferies LLC, Research Division
David Bailey - Morgan Stanley, Research Division
Craig Wong-Pan - RBC Capital Markets, Research Division
Christine Trinh - Macquarie Research

Presentation

Operator

Welcome to the Fisher & Paykel Healthcare FY '26 Results Announcement. My name is Justin, and I will be your operator for today's call. [Operator Instructions] Please note, this conference call is being recorded.

I would now like to turn the call over to Marcus Driller, VP Corporate.

Marcus Driller
Vice President of Corporate

Thank you, Justin. Good morning, everyone, and welcome to the conference call for Fisher & Paykel Healthcare's full year results for the 2026 financial year. On the call today, with me and Dan are Lewis Gradon, our Managing Director and CEO; Lyndal York, our Chief Financial Officer; Andy Niccol, our Chief Operating Officer; Justin Callahan, our VP of Sales and Marketing; and Andrew Somervell, our VP of Products and Technology. Lewis and Lyndal will first provide an overview of the results, and then we'll move on to questions. We'll be discussing our results for the 12 months ended 31 March 2026.

此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。